1. Anti-EGFR-resistant clones decay exponentially after progression: implications for anti-EGFR re-challenge. (21st November 2018) Authors: Parseghian, C M; Loree, J M; Morris, V K; Liu, X; Clifton, K K; Napolitano, S; Henry, J T; Pereira, A A; Vilar, E; Johnson, B; Kee, B; Raghav, K; Dasari, A; Wu, J; Garg, N; Raymond, V M; Banks, K C; Talasaz, A A; Lanman, R B; Strickler, J H Journal: Annals of oncology Issue: Volume 30:Number 2(2019) Page Start: 243 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Phase II study of nab-paclitaxel in refractory small bowel adenocarcinoma and CpG island methylator phenotype (CIMP)-high colorectal cancer. (23rd October 2017) Authors: Overman, M J; Adam, L; Raghav, K; Wang, J; Kee, B; Fogelman, D; Eng, C; Vilar, E; Shroff, R; Dasari, A; Wolff, R; Morris, J; Karunasena, E; Pisanic, R; Azad, N; Kopetz, S Journal: Annals of oncology Issue: Volume 29:Number 1(2018) Page Start: 139 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Phase II study of nab-paclitaxel in refractory small bowel adenocarcinoma and CpG island methylator phenotype (CIMP)-high colorectal cancer. (3rd July 2018) Authors: Overman, M J; Adam, L; Raghav, K; Wang, J; Kee, B; Fogelman, D; Eng, C; Vilar, E; Shroff, R; Dasari, A; Wolff, R; Morris, J; Karunasena, E; Pisanic, T R; Azad, N; Kopetz, S Journal: Annals of oncology Issue: Volume 30:Number 3(2019) Page Start: 495 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗